Danaher

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Danaher 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About DHR

Danaher Corp. engages in the design, manufacture, and marketing of professional, medical, industrial, and commercial products and services. It operates through the following segments: Biotechnology, Life Sciences, and Diagnostics. 

CEO
Rainer M. Blair
CEORainer M. Blair
Employees
63,000
Employees63,000
Headquarters
Washington, District of Columbia
HeadquartersWashington, District of Columbia
Founded
1984
Founded1984
Employees
63,000
Employees63,000

DHR Key Statistics

Market cap
152.93B
Market cap152.93B
Price-Earnings ratio
42.89
Price-Earnings ratio42.89
Dividend yield
0.59%
Dividend yield0.59%
Average volume
5.10M
Average volume5.10M
High today
$218.40
High today$218.40
Low today
$214.56
Low today$214.56
Open price
$216.68
Open price$216.68
Volume
4.31M
Volume4.31M
52 Week high
$242.80
52 Week high$242.80
52 Week low
$171.00
52 Week low$171.00

Stock Snapshot

Danaher(DHR) stock is priced at $216.61, giving the company a market capitalization of 152.93B. It carries a P/E multiple of 42.89 and pays a dividend yield of 59.1%.

On 2026-02-07, Danaher(DHR) stock moved within a range of $214.56 to $218.40. With shares now at $216.61, the stock is trading +1.0% above its intraday low and -0.8% below the session's peak.

Trading activity shows a volume of 4.31M, compared to an average daily volume of 5.1M.

Over the past 52 weeks, Danaher(DHR) stock has traded between a high of $242.80 and a low of $171.00.

Over the past 52 weeks, Danaher(DHR) stock has traded between a high of $242.80 and a low of $171.00.

DHR News

Simply Wall St 22h
Do Danaher’s Bioprocessing Gains and Buybacks Reveal a Sharper Strategic Focus for DHR?

Danaher Corporation recently reported full-year 2025 results, with sales rising to US$24.57 billion while net income and earnings per share from continuing oper...

Do Danaher’s Bioprocessing Gains and Buybacks Reveal a Sharper Strategic Focus for DHR?
Simply Wall St 2d
Is Danaher Fairly Priced After Recent Share Price Weakness?

If you are wondering whether Danaher's current share price lines up with its underlying value, you are not alone. This article is designed to help you size that...

Is Danaher Fairly Priced After Recent Share Price Weakness?
Simply Wall St 5d
Assessing Danaher Valuation After 2025 Sales Growth But Weaker Earnings

Danaher (DHR) has released its full year 2025 results, reporting sales of US$24.6b compared to US$23.9b a year earlier, while net income and earnings per share...

Assessing Danaher Valuation After 2025 Sales Growth But Weaker Earnings

Analyst ratings

89%

of 28 ratings
Buy
89.3%
Hold
10.7%
Sell
0%

People also own

Based on the portfolios of people who own DHR. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.